BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23385820)

  • 1. Derivation, characterization and retinal differentiation of induced pluripotent stem cells.
    Mekala SR; Vauhini V; Nagarajan U; Maddileti S; Gaddipati S; Mariappan I
    J Biosci; 2013 Mar; 38(1):123-34. PubMed ID: 23385820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zic3 enhances the generation of mouse induced pluripotent stem cells.
    Declercq J; Sheshadri P; Verfaillie CM; Kumar A
    Stem Cells Dev; 2013 Jul; 22(14):2017-25. PubMed ID: 23421367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing Pluripotency in the Domestic Cat (
    Dutton LC; Dudhia J; Guest DJ; Connolly DJ
    Stem Cells Dev; 2019 Oct; 28(19):1299-1309. PubMed ID: 31389301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
    Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
    BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
    Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
    Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells.
    Anchan R; Gerami-Naini B; Lindsey JS; Ho JW; Kiezun A; Lipskind S; Ng N; LiCausi JA; Kim CS; Brezina P; Tuschl T; Maas R; Kearns WG; Williams Z
    PLoS One; 2015; 10(3):e0119275. PubMed ID: 25751620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
    Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
    Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
    Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
    Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.
    Jin ZB; Okamoto S; Xiang P; Takahashi M
    Stem Cells Transl Med; 2012 Jun; 1(6):503-9. PubMed ID: 23197854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
    Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
    Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
    Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
    Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in transcription patterns between induced pluripotent stem cells produced from the same germ layer are erased upon differentiation.
    Pirozhkova I; Barat A; Dmitriev P; Kim E; Robert T; Guégan J; Bilhou-Nabera C; Busato F; Tost J; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky Y
    PLoS One; 2013; 8(1):e53033. PubMed ID: 23326377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-induced pluripotent stem cells produced under xeno-free conditions.
    Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
    Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
    Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
    Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.